Admission Date:  [**2117-9-14**]       Discharge Date:  [**2117-11-11**]

Date of Birth:   [**2047-6-7**]       Sex:  M

Service:  Transplant Surgery

HISTORY OF PRESENT ILLNESS:  The patient is a 70 year old
male with a history significant for end stage renal disease
secondary to diabetes mellitus, status post cadaveric renal
transplant in [**2115-5-28**], hypertension, status post
cerebrovascular accident, status post myocardial infarction
and congestive heart failure with an ejection fraction of 15
to 20% and diverticulitis who was admitted to [**Hospital6 1760**] with heart failure,
myocardial infarction and renal failure on [**2117-9-14**].
The patient was admitted to the Medical Intensive Care Unit
and was medically managed.

PHYSICAL EXAMINATION:  The patient is an obese older male in
moderate respiratory distress on admission.  The patient was
awake and following commands, neurologically intact.  The
patient had bilateral crackles on lung examination.  Cardiac
examination was regular rate and rhythm without murmur or
gallop.  The abdomen was obese with a percutaneous endoscopic
gastrostomy tube.  Lower extremities were cool with palpable
distal pulses.

LABORATORY DATA:  Chest x-ray was significant for pulmonary
edema with pleural effusion.  Electrocardiogram was
significant for sinus rhythm with inferior Q waves.

HOSPITAL COURSE:  The patient was medically managed in the
Intensive Care Unit with a prolonged course of renal failure
and congestive heart failure.  The patient then developed
worsening of diverticular disease with significant
diverticulitis requiring a sigmoid colectomy on [**2117-10-19**].  Postoperatively the patient was transferred to the
Transplant Surgery Service.  The patient was intubated in
respiratory failure with acute renal failure and required
aggressive diuresis with Natrecor as well as inotropic
support with Dobutamine.  Over the course of the next three
weeks, the patient had recovering renal function from acute
renal failure and was aggressively diuresed.  Significant
infections included Enterobacter central line infection as
well as Enterobacter pneumonia.  The patient was treated with
Meropenem and will be complete a course of three weeks.  The
patient was also empirically treated for Clostridium
difficile colitis with a course of Flagyl for ten days.
During the postoperative period a tracheostomy was placed and
the patient was weaned from the ventilator.  The patient
continued to improve with an improvement in mental status.
The patient was awake and following commands and pulmonary
function, to be off the ventilator on a tracheostomy collar.
The patient's creatinine normalized to a level of 0.9.  The
patient's gastrointestinal tract recovered and the patient
was tolerating tube feeds at goal.  The patient was afebrile
with a normal white count by the end of the hospital stay.

CONDITION ON DISCHARGE:  Good.

DISCHARGE STATUS:  Stable.

DISCHARGE DIAGNOSIS:
1.  Congestive heart failure
2.  Status post myocardial infarction
3.  Acute renal failure
4.  History of end stage renal disease secondary to diabetes
mellitus status post cadaveric renal transplant in [**2115-5-28**]
5.  Diabetes mellitus
6.  Hypertension
7.  Status post cerebrovascular accident
8.  Diverticulitis status post sigmoid colectomy and
[**Doctor Last Name 3379**] procedure with colostomy on [**2117-10-19**].
10. Status post tracheostomy on the date of [**2117-11-2**].
11. Sacral decubitus ulcer.
12. Enterobacter pneumonia and central line infection.

DISCHARGE MEDICATIONS:
1.  Bactrim single strength one tablet p.o. q. Tuesday and
Thursday
2.  Bacitracin ointment apply to bilateral heel ulcers b.i.d.
3.  Miconazole powder, 2% apply to bilateral groins t.i.d.
4.  Zoloft 100 mg p.o. q.d.
5.  Heparin 5000 units subcutaneously q. 8
6.  Aspirin 800 mg p.o. q.d.
7.  Epogen 4000 units subcutaneously q. Monday
8.  Prednisone 10 mg p.o. q.d.
9.  CellCept 1 gm p.o. b.i.d
10. Meropenem 1 gm intravenously q. 12
11. Amiodarone 400 mg per percutaneous endoscopic gastrostomy
tube q.d.
12. Pepcid 20 mg per percutaneous endoscopic gastrostomy tube
b.i.d.
13. Hydralazine 10 mg per percutaneous endoscopic gastrostomy
tube q.i.d.
14. Lopressor 25 mg per percutaneous endoscopic gastrostomy
tube b.i.d.
15. Insulin sliding scale
16. Insulin NPH 20 units in the morning and 20 units at night
17. Lasix 20 mg per percutaneous endoscopic gastrostomy tube
b.i.d.
18. Prograf 2 mg p.o. b.i.d.

FOLLOW UP PLANS:  The patient is follow up with Dr. [**First Name8 (NamePattern2) **]
[**Last Name (NamePattern1) **] of Transplant Surgery.  The patient is also to follow
up with Nephrology at the [**Hospital6 2018**].  The patient is to follow up with his primary care
physician.



                            [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], M.D.  [**MD Number(1) 1331**]

Dictated By:[**Name8 (MD) 26116**]
MEDQUIST36

D:  [**2117-11-10**]  18:12
T:  [**2117-11-10**]  18:50
JOB#:  [**Job Number 26117**]
